Sep 10, 2014 | News
G2 will be attending IIBIG’s 2nd Annual Forum on Optimizing Clinical Research Performance. In 2013, CenterWatch’s inaugural forum on Optimizing Clinical Research Performance, presented in association with iiBIG, became one of the industry’s must-attend conferences for its unique, trend-setting, strategic content and innovative solutions with topics based on original research and analysis featured in The CenterWatch Monthly and CWWeekly newsletters, two of the industry’s leading news publications. September 15-16, 2014 in Boston, CenterWatch introduces its 2nd annual forum — presented in a new day-and-a-half format featuring more general sessions and strategically positioned break-out discussions — intended to foster compelling and actionable conversations among senior-level, clinical research professionals from pharma, CROs, investigative sites and niche service providers. This revised forum will welcome more than 30 thought leaders and presenters at the forefront of driving change across the global clinical research landscape through novel collaboration and creative solutions. Sessions will focus on key emerging trends — chosen by the CenterWatch conference team and supported by informative data and implementable strategies — on topics such as the evolution of patient partnerships, recruitment and retention strategies, vital technology drivers, critical regulatory changes and more, to propel powerful and insightful dialogue that will extend well beyond the conference rooms and networking breaks. For more go to iibig.com...
Aug 27, 2014 | News
Now more than ever we need to bridge the Gap between patients and researchers. G2 can help your physicians conduct clinical trials in their office settings. The planning of clinical trials to test new drugs for safety and effectiveness is no picnic under the best of circumstances. It requires a grasp of medicine, pharmacology and statistics, among other disciplines. However, when the disease or syndrome for which the drug is intended is not well circumscribed but is instead a spectrum of entities, it can be far more difficult. That makes the concept of “enrichment” critical. Clinical trials are not designed or intended to show the effectiveness of a treatment (drug, medical device or other intervention) in a completely random sample of people in the general population. Instead, researchers use a variety of strategies to select a subset of patients in whom the intervention will likely be demonstrable. This process is “enrichment,” the prospective use of any patient characteristic (including laboratory test values) to select subjects in whom detection of an effect is more likely than it would be in an unselected population. — Continue reading at Forbes.com »...
Aug 12, 2014 | News
After a decorative plate fell off the wall and put a gash in the side of Tina Melgar’s face late last month, she went to MemorialCare’s urgent care clinic in her Los Altos neighborhood of Long Beach and was seen almost immediately. The medical team gave her four stitches, and a week later she was back – no appointment necessary – to have them taken out. Had the same mishap occurred a few years ago, Melgar says, she would have gone to the emergency room at Long Beach Memorial – also owned by MemorialCare – and probably waited several hours to be seen. “They would have charged me $200, I’m sure,” Melgar says. Her co-pay for the urgent care visit will be $20, and “because I was in such misery, they didn’t ask me for any money at the time.” Melgar is not the only one to discover that she can get good care much more quickly and cheaply at an urgent care clinic than in a hospital emergency department. Hospitals, under mounting pressure to deliver care more cost-effectively, are switching to outpatient settings and discouraging the use of their emergency rooms for conditions that are not threatening to life or limb. Urgent care clinics are booming across the nation, as venture capitalists, large health systems and even insurance companies see growing patient volume and cost-efficient medical care driving strong returns on investment. Read the full article at ocregister.com Find out how G2 can help your UC increase revenues by adding clinical trials to your business...
Aug 7, 2014 | News
At G2 we are aware that technology will play a great part in the future of clinical trials. This is just one example of how technology can improve trial outcomes and efficacy. Smartphones offer us incredible new opportunities for implementing efficient clinical research trials. They allow researchers to simplify complexities that have traditionally surrounded clinical research with tools that are now easily accessible to both practitioners and patients. Smartphones can be used to gather critical information from an enrolled patient including factors such as weight, blood pressure, glucose levels, and more. Not only can smartphones be used to automate and speed up information entry, they offer ways to improve the methodology and accuracy of research. Here are 5 issues making clinical research less efficient as well as costly, and how smartphones can help significantly improve the process....
Jul 23, 2014 | News
G2 Clinical Research Consulting will be attending the AACC 2014 Annual Meeting & Clinical Lab Expo to connect with the global laboratory medicine community. Connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine. Learn about cutting edge technology. The AACC annual meeting has more than 200 new product introductions each year. Hear vital research and learn about important changes in the field. With more than 200 educational opportunities in Lectures, Plenary Sessions, Symposia, Short Courses and Brown Bag Sessions, you can design an educational experience that best meets your professional needs. For more on AACC and the expo click...
Jul 10, 2014 | News
Instead, they have turned to one of the fastest-growing segments of American health care: urgent care, a common category of walk-in clinics with uncommon interest from Wall Street. Once derided as “Doc in a Box” medicine, urgent care has mushroomed into an estimated $14.5 billion business, as investors try to profit from the shifting landscape in health care. G2 is here to help you increase revenues for your practice or urgent care center. With the proliferation of urgent care centers as recently described in the New York Times, we can be a valuable resource to make sure your urgent care center is profitable in this competitive...
